This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Laurus Labs Private Limited. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyderabad, IN (2021)
- Visakhapatnam, IN (2022)
Company Filing History:
Years Active: 2021-2022
Title: Innovations of Jagadeeswara Rao Dadi
Introduction
Jagadeeswara Rao Dadi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of key intermediates and processes for drug synthesis. With a total of 2 patents, his work has implications for the treatment of various medical conditions.
Latest Patents
One of his latest patents is titled "Process for preparation of 2-Amino-5-hydroxy propiophenone." This invention relates to a process for preparing 2-Amino-5-hydroxy propiophenone, which is a crucial intermediate for synthesizing camptothecin analogs, including 7-Ethyl-10-hydroxycamptothecin (SN-38). Another significant patent is "Process for the preparation and particle size reduction of pirfenidone." This invention describes an improved process for preparing pure pirfenidone with a specific particle size distribution, along with methods for particle size reduction using various techniques such as wet milling.
Career Highlights
Jagadeeswara Rao Dadi is currently associated with Laurus Labs Private Limited, a prominent company in the pharmaceutical sector. His work at Laurus Labs has allowed him to focus on innovative processes that enhance drug formulation and efficacy.
Collaborations
He has collaborated with several professionals in his field, including Uma Maheswer Rao Vasireddi and Venkata Ramana Kintali. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Jagadeeswara Rao Dadi's contributions to pharmaceutical innovations highlight his expertise and commitment to improving drug development processes. His patents reflect a dedication to advancing medical science and enhancing treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
